Toyobo Co (3101) Q2 2025 earnings summary

Executive summary

• Net sales increased 4.9% year-over-year to ¥209.2 billion in H1 FY 3/25, with operating profit up 193.5% to ¥6.9 billion and ordinary profit up 206.5% to ¥3.2 billion.

• Net profit dropped 94.3% year-over-year to ¥0.1 billion, mainly due to losses on disposal of fixed assets, extraordinary losses, and exchange fluctuations.

• Comprehensive income fell 51.4% year-over-year to ¥2.0 billion.

• Operating profit growth was driven by improvements in Industrial Film, Environmental and Functional Materials, and Functional Textiles, while Life Science saw a decline.

Financial highlights

• H1 FY 3/25: net sales ¥209.2 billion (+4.9% YoY), operating profit ¥6.9 billion (+193.5% YoY), ordinary profit ¥3.2 billion (+206.5% YoY), EBITDA ¥18.1 billion (+54.0% YoY).

• EPS for H1 FY 3/25 was ¥1.3; ROE annualized at 0.1%.

• Operating cash flow increased 69.6% year-over-year to ¥17.1 billion.

• CAPEX decreased 16.6% year-over-year to ¥25.0 billion; R&D expenses down 6.4% to ¥7.2 billion.

• Net profit per share: ¥1.29 (down from ¥22.82 year-over-year).

Outlook and guidance

• FY 3/25 forecasts: net sales ¥435.0 billion (+5.0% YoY), operating profit ¥17.0 billion (+89.0% YoY), ordinary profit ¥11.5 billion (+65.2% YoY), net profit ¥2.6 billion (+5.9% YoY), net profit per share ¥29.50.

• No changes to previously announced earnings forecast.

• Profit improvement expected in Packaging Film and Life Science, with volume increases in electronic materials and cost reductions.

• Segment forecasts: Films operating profit to rise to ¥6.5 billion, Environmental and Functional Materials to ¥8.0 billion.